Article Details

PCSK9 Monoclonal Antibody Provides 'Significant and Durable' Decrease in LDL-C

Retrieved on: 2022-11-16 02:31:08

Tags for this article:

Click the tags to see associated articles and topics

PCSK9 Monoclonal Antibody Provides 'Significant and Durable' Decrease in LDL-C. View article details on HISWAI: https://www.physiciansweekly.com/pcsk9-monoclonal-antibody-provides-significant-and-durable-decrease-in-ldl-c/

Excerpt

“Currently approved proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies demonstrated robust LDL-C-lowering efficacy at ...

Article found on: www.physiciansweekly.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up